Publication stageIn Press Journal Pre-Proof
The COVID-19 pandemic has had an impact on diabetes care in the US, Canada and the UK, including on diagnostics and ongoing treatment
Our study corroborates previous studies and adds to the growing literature on the impact of the pandemic restrictions on routine diabetes care.
Author disclosures: Alice Cheng, Stewart Harris, Iris Krawchenko, Ronald Goldenberg and Richard Tytus received advisory fees from IQVIA Solutions Canada Inc for contributions to the design and interpretation of the study but received no compensation for development of the manuscript. Jina Hahn and Aiden Liu are employees of Novo Nordisk Canada Inc. Brad Millson and Shane Golden are employed by IQVIA Solutions Canada Inc to support this Novo Nordisk Canada Inc sponsored study.
User licenseCreative Commons Attribution (CC BY 4.0) |
- Read, print & download
- Redistribute or republish the final article
- Text & data mine
- Translate the article
- Reuse portions or extracts from the article in other works
- Sell or re-use for commercial purposes
Elsevier's open access license policy